Abstract
There is a strong association between maternal pre-existing diabetes type 1 and an increased risk for congenital malformations, e.g., congenital heart defects. There is no certain difference according to the type of insulin used. Pre-existing diabetes type 2 also seems to be associated with an increased risk for congenital malformations although less strong than that of diabetes type 1. The use of oral hypoglycemic drugs in this situation seems not to carry a further risk. It is important to have a good glycemic control already when pregnancy begins in order to minimize the malformation risk.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bell R, Bailey K, Cresswell T, Hawthorne G, Critchley J, Lewis-Barned N. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG. 2008;115:445–52.
Botta RM. Congenital malformations in infants of 517 pregestational diabetic mothers. Ann Ist Super Sanita. 1997;33:307–11.
Cassina M, Donà M, Di Gianantonio E, Litta P, Clementi M. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:656–69.
Cea-Soriano L, Garcia-Rodriquez LA, Brodovicz KG, Masso Gonzalez E, Bartels DB, Hernández-Diaz S. Safety of non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: a cohort study. Diabetes Obes Metab. 2018;20(7):1642–51. https://doi.org/10.1111/dom.13275.
Evers IM, de Valk HW, Visser GHA. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328(7445):915. https://doi.org/10.1136/bmj.38043.583160.EE.
Frias JL, Frias JP, Frias PA, Martinez-Frias ML. Infrequently studied congenital anomalies as clues to the diagnosis of maternal diabetes mellitus. Am J Med Genet. 2007;143A:2904–9.
Given JE, Loane M, Game E, Addor M-C, Bakker M, Bertaut-Nativel B, Gatt M, Klungsoyr K, Lelong N, Morgan M, Neville AJ, Pierini A, Rissman A, Dolk H. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ. 2018;361:k2477. https://doi.org/10.1136/bmj.k2477.
Gutzin SJ, Kozer E, Magee LA, Feig DS, Koren G. The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis. Can J Clin Pharmacol. 2003;10:179–83.
Kalter H. Case reports of malformations associated with maternal diabetes: history and critique. Clin Genet. 1993;43:174–9.
Ludvigsson JF, Neovius M, Söderling J, Gudbjörnsdottir S, Svensson A-M, Franzén S, Stephansson O, Pasternak B. Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden. BMJ. 2018;362:k2638. https://doi.org/10.1136/bmjk2638.
Øyen N, Diaz LJ, Leirgul E, Boyd HA, Priest J, Mathiesen ER, Quertermous T, Wohlfart J, Melbye M. Prepregnancy diabetes and offspring congenital heart disease: a nationwide cohort study. Circulation. 2016;133:2243–53.
Passarge E, Lenz W. Syndrome of caudal regression in infants of diabetic mothers: observations of further cases. Pediatrics. 1966;37:672–5.
Pedersen LM, Tygstrup I, Pedersen J. Congenital malformations in newborn infants of diabetic mothers. Correlation with maternal diabetic vascular complications. Lancet. 1964;i:1124–6.
Piacquadio K, Hollingworth DR, Murphy H. Effects of in-utero exposure to oral hypoglycaemic drugs. Lancet. 1991;338:866–9.
Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH, Buchanan TA. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care. 1995;18:1446–51.
Wren C, Birrell G, Howthorne G. Cardiovascular malformations in infants of diabetes mothers. Heart. 2003;87:1217–20.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Källén, B. (2019). Maternal Use of Insulin or Oral Hypoglycemic Drugs and Infant Congenital Malformations. In: Maternal Drug Use and Infant Congenital Malformations. Springer, Cham. https://doi.org/10.1007/978-3-030-17898-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-17898-7_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17897-0
Online ISBN: 978-3-030-17898-7
eBook Packages: MedicineMedicine (R0)